Stonepine Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-755,000
Closed -$2.86M 29
2020
Q1
$2.86M Buy
+755,000
New +$3.71M 3.03% 18
2019
Q4
Sell
-2,595,855
Closed -$10.9M 32
2019
Q3
$10.9M Sell
2,595,855
-168,620
-6% -$720K 10.61% 3
2019
Q2
$12.9M Buy
2,764,475
+1,225,038
+80% +$5.7M 8.85% 4
2019
Q1
$8.16M Sell
1,539,437
-2,442,430
-61% -$11.2M 4.69% 6
2018
Q4
$14.7M Sell
3,981,867
-329,236
-8% -$1.16M 12.94% 2
2018
Q3
$12.1M Buy
4,311,103
+2,825,101
+190% +$7.93M 7.06% 4
2018
Q2
$4.38M Sell
1,486,002
-2,220,082
-60% -$5.26M 2.66% 13
2018
Q1
$8.34M Buy
3,706,084
+60,593
+2% +$142K 4.47% 8
2017
Q4
$10.8M Sell
3,645,491
-221,909
-6% -$613K 6.45% 6
2017
Q3
$11.4M Buy
3,867,400
+389,727
+11% +$1.19M 6.73% 6
2017
Q2
$9.74M Buy
3,477,673
+632,853
+22% +$1.34M 5.26% 7
2017
Q1
$5.41M Buy
2,844,820
+244,109
+9% +$471K 3.05% 12
2016
Q4
$4.55M Buy
+2,600,711
New +$5.31M 2.71% 13
2016
Q2
Sell
-8,523
Closed -$28K 29
2016
Q1
$28K Buy
+8,523
New +$31.5K 0.03% 19

Other funds holding BDSI

Stonepine Capital Management's BDSI Position: Q2 2020 in Review

Stonepine Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 755,000 shares — an estimated $2.86M sold.

Stonepine Capital Management first reported a position in BDSI in Q1 2016 and held it in 14 quarters. The position peaked at $14.7M in Q4 2018. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • Stonepine Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
  • Stonepine Capital Management sold 755,000 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $2.86M.
  • Stonepine Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2016 and held it in 14 quarters.
  • Stonepine Capital Management's BioDelivery Sciences International, Inc. position peaked at $14.7M in Q4 2018.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on Stonepine Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.